An example of this is the study by Chafetz et al., which revealed that the serum level of Placental Protein 13 (PP13), also known as galectin-13, is decreased during the first trimester in women later diagnosed with pre-eclampsia, intrauterine growth restriction (IUGR), and preterm deliveries. This evidence concerns the gene LGALS13 and fetal growth restriction.